More recently linsitinib (OSI-906), a novel small-molecule dual IGF1R/IR kinase inhibitor, demonstrated anti-proliferative effects in vitro and in vivo in both stem like and colorectal cancer models [19]. This evidence concerns the gene IGF1R and colorectal cancer.